Skip to main content

Table 5 Association between invasive therapy and 28-day-case fatality by age category

From: Predictors of non-invasive therapy and 28-day-case fatality in elderly compared to younger patients with acute myocardial infarction: an observational study from the MONICA/KORA Myocardial Infarction Registry

  Age category
25–64 years 65–74 years 75–84 years
OR [95 % CI] p Value OR [95 % CI] p Value OR [95 % CI] p Value
Model 1a 0.19 [0.10–0.36] <0.0001 0.28 [0.17–0.46] <0.0001 0.43 [0.30–0.62] <0.0001
Model 2b 0.35 [0.15–0.84] 0.02 0.45 [0.22–0.92] 0.03 0.39 [0.24–0.63] <0.0001
  1. a Model 1 adjusted for sex for the total sample (n = 3475)
  2. b Model 2 adjusted for sex, body mass index ≥30 kg/m2, type of AMI, renal dysfunction, prior stroke, prior MI, history of diabetes, hypertension, hyperlipidemia, angina pectoris and chronic obstructive pulmonary disease, any in-hospital complication (without cardiac arrest), pre-hospital time, left ventricular ejection fraction, peak serum creatine phosphokinase (CPK) level, and in-hospital medication: dual antiplatelet therapy, beta-blockers, statins, and angiotensin-converting-enzyme inhibitors or angiotensin receptor blockers. As 23 patients had no data on peak serum CPK level, the total sample size was 3452